These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9673846)
21. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study. Endrikat J; Düsterberg B; Ruebig A; Gerlinger C; Strowitzki T Contraception; 1999 Nov; 60(5):269-74. PubMed ID: 10717778 [TBL] [Abstract][Full Text] [Related]
22. Reciprocal coordination of a combination oral contraceptive containing desogestrel+ethinyl estradiol on the expression of LOX-1 and LDLR in placental trophoblast cells. Pandey H; Arjuman A; Roy KK; Chandra NC Contraception; 2011 Dec; 84(6):e43-9. PubMed ID: 22078205 [TBL] [Abstract][Full Text] [Related]
23. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Ahrendt HJ; Nisand I; Bastianelli C; Gómez MA; Gemzell-Danielsson K; Urdl W; Karskov B; Oeyen L; Bitzer J; Page G; Milsom I Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101 [TBL] [Abstract][Full Text] [Related]
24. Vaginal ring contraception. Kerns J; Darney P Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335 [TBL] [Abstract][Full Text] [Related]
25. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women. Petersen KR; Sidelmann J; Skouby SO; Jespersen J Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344 [TBL] [Abstract][Full Text] [Related]
26. [Novynette--trends in contraception at the beginning of the new millennium]. Ivanov S; Sigridov I Akush Ginekol (Sofiia); 2004; 43 Suppl 2():30-2. PubMed ID: 15518273 [No Abstract] [Full Text] [Related]
27. The 3-keto-desogestrel/ethinylestradiol ring: a new parenteral form of hormonal contraception. Schindler AE Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):13-4. PubMed ID: 8365506 [No Abstract] [Full Text] [Related]
28. Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel. Basdevant A; Conard J; Pelissier C; Guyene TT; Lapousterle C; Mayer M; Guy-Grand B; Degrelle H Contraception; 1993 Sep; 48(3):193-204. PubMed ID: 8222650 [TBL] [Abstract][Full Text] [Related]
29. Clinical review of a monophasic oral contraceptive containing desogestrel and ethinyl estradiol. Stone S Int J Fertil; 1992; 37(5):286-9. PubMed ID: 1358840 [No Abstract] [Full Text] [Related]
30. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation. Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850 [TBL] [Abstract][Full Text] [Related]
31. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance. Endrikat J; Jaques MA; Mayerhofer M; Pelissier C; Müller U; Düsterberg B Contraception; 1995 Oct; 52(4):229-35. PubMed ID: 8605781 [TBL] [Abstract][Full Text] [Related]
33. Ovarian activity suppression by two different low-dose triphasic oral contraceptives. van der Does J; Exalto N; Dieben T; Bennink HC Contraception; 1995 Dec; 52(6):357-61. PubMed ID: 8749599 [TBL] [Abstract][Full Text] [Related]
34. Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments. Koyuncu FM; Kuscu NK; Var A; Onur E Acta Obstet Gynecol Scand; 2003 Aug; 82(8):767-8. PubMed ID: 12848650 [No Abstract] [Full Text] [Related]
35. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters. Jung-Hoffmann C; Fitzner M; Kuhl H Horm Res; 1991; 36(5-6):238-46. PubMed ID: 1823082 [TBL] [Abstract][Full Text] [Related]
36. A multicenter efficacy and safety study of an oral contraceptive containing 150 micrograms desogestrel and 30 micrograms ethinyl estradiol. Walling M Contraception; 1992 Oct; 46(4):313-26. PubMed ID: 1486770 [TBL] [Abstract][Full Text] [Related]
37. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol. Bonnar J; Daly L; Carroll E Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344 [TBL] [Abstract][Full Text] [Related]
38. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive. Anttila L; Kunz M; Marr J Contraception; 2009 Nov; 80(5):445-51. PubMed ID: 19835718 [TBL] [Abstract][Full Text] [Related]
39. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369 [TBL] [Abstract][Full Text] [Related]
40. Influence of hormonal contraceptives on microbial flora of gingival sulcus. Klinger G; Eick S; Klinger G; Pfister W; Gräser T; Moore C; Oettel M Contraception; 1998 Jun; 57(6):381-4. PubMed ID: 9693397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]